Skip to content
  • HOME
  • ABOUT

    CPA is the leading national, bipartisan organization exclusively representing domestic producers and workers across many industries and sectors of the U.S. economy.

    • ABOUT CPA
    • STAFF
    • BOARD
    • CONTACT CPA
    • ABOUT CPA
    • STAFF
    • BOARD
    • CONTACT CPA
    LEARN MORE ➔
  • ISSUES

    CPA ADVOCACY ISSUES

    • AGRICULTURE
    • BUY AMERICAN
    • CHINA
    • CURRENCY
    • DE MINIMIS
    • AGRICULTURE
    • BUY AMERICAN
    • CHINA
    • CURRENCY
    • DE MINIMIS
    • HEALTHCARE
    • MANUFACTURING
    • RENEWABLE ENERGY
    • TAX
    • TECHNOLOGY
    • TRADE & TARIFFS
    • HEALTHCARE
    • MANUFACTURING
    • RENEWABLE ENERGY
    • TAX
    • TECHNOLOGY
    • TRADE & TARIFFS
  • NEWSROOM
    CPA Calls for Strong Tariff Protection to Support U.S. Commercial Vehicle Production

    CPA Calls for Strong Tariff Protection to Support U.S. Commercial Vehicle Production

    August 24, 2026

    THE LATEST

    • NEWSLETTER: PROSPER WEEKLY
    • PRESS RELEASES
    • CPA OPINION
    • LETTERS & TESTIMONY
    • NEWSLETTER: PROSPER WEEKLY
    • PRESS RELEASES
    • CPA OPINION
    • LETTERS & TESTIMONY

    CPA Calls for Strong Tariff Protection to Support U.S. Commercial Vehicle Production

    CPA: U.S. Must Hold the Line on Section 232 Steel and Aluminum Tariffs

    CPA Warns USTR: America’s Section 232 Metals Tariffs Are National Security Measures, Not Bargaining Chips

    CPA Commends Trump Administration for Exposing the Great Transshipment Scam; Urges Tariffs Designed to Defeat It

    MORE FROM THE NEWSROOM ➔
  • RESEARCH
  • CONTRIBUTE

    Help us take the next steps to strengthen America's domestic producers.

    Your generous contribution will enable us to keep fighting for the prosperous growth of an industrial strategy in many sectors such as Healthcare, Agriculture, Manufacturing, Trade, Technology & Tax.

    CONTRIBUTE TODAY ➔

After China Balloon Incident, House Financial Services Talks Risks To US

Issues, China, CPA News, NewsroomBy Kenneth RapozaFebruary 16, 2023Leave a comment

What are the risks China poses to the U.S. industrial supply chain and what can be done about it? Some quotes from Congress and witnesses from a Feb. 7 hearing.

Pharmaceuticals Are Heavily Outsourced. Can the U.S. Make More of it Here?

Archive, commentary, Commentary Featured, Featured Home Page, Healthcare, Issues, NewsroomBy Kenneth RapozaJanuary 30, 2023Leave a comment

The U.S. is increasingly dependent on imports for drugs. One reason: a tax avoidance scheme that pits U.S. manufacturing up against Europe. What can be done about this problem?

European Pharma Considers Reshoring from India, China. Where’s the US?

Archive, commentary, Commentary Featured, Featured Home Page, Healthcare, Issues, NewsroomBy Kenneth RapozaJanuary 23, 2023Leave a comment

The Covid-19 pandemic gave big pharma big payday. But it also caused the industry to rethink a globalized supply chain centered on Asia. What will it take to reshore at least some generic drugs to the U.S.

Supply Chain Dependence Makes Reshoring Harder – McKinsey

Archive, commentary, Commentary Featured, Featured Home Page, Issues, Manufacturing, Newsroom, Supply ChainBy Kenneth RapozaJanuary 13, 2023Leave a comment

Can the U.S. really bring manufacturing home? A McKinsey study shows that existing concentration of some supply chains will make it hard. Here’s what needs to be done.

Skyrocketing Pharmaceutical Imports to the U.S. Endanger National Security

Archive, Featured Home Page, Featured Research, Healthcare, Research, Research Hub ArticlesBy Andrew HeritageJanuary 9, 2023Leave a comment

U.S. pharmaceutical imports have skyrocketed in the last ten years, with imports from China, India and Mexico leading the surge.

India Drug Maker Aurobindo Keeps Getting Poor Grades by the FDA

Archive, commentary, Commentary Featured, Featured Home Page, Healthcare, Issues, NewsroomBy Kenneth RapozaDecember 15, 2022Leave a comment

One of India’s pharmaceutical labs has run afoul of the FDA many times this year. The U.S. is dependent on foreign labs like Aurobindo for its drug supply. Can the government help change that?

As 2022 Draws to a Close, Globalization is Still Against the Ropes

Archive, commentary, Commentary Featured, Featured Home Page, Issues, Newsroom, Trade and TariffsBy Kenneth RapozaDecember 13, 2022Leave a comment

As 2022 winds down, one thing remains clear, globalization is losing support among policy makers, and even among influencers like Paul Krugman.

China’s Ever-Expanding Orwellian State is a Warning to the US – Congressional Hearing

Featured Home Page, Capital Markets, China, CPA News, Customs, Healthcare, Issues, NewsroomBy Kenneth RapozaNovember 16, 2022Leave a comment

The Congressional-Executive Commission on China hears testimony about Zero Covid and the human rights abuses its exacerbated in the world’s No. 2 economy. In a report by the Commission, calls for more capital market sanctions.

Here’s How Pharmaceutical Drugs Are Recalled. And Why Some Might Still Remain on the Shelves.

Featured Home Page, Archive, commentary, Commentary Featured, Healthcare, Issues, NewsroomBy CPA NewsroomNovember 3, 2022Leave a comment

Most people think that when a drug is recalled by the lab, it is pulled from pharmacy shelves. It’s not. Here’s how drug recalls really work.

Mighty Dollar – Mighty Wrong

Research Hub Articles, ArchiveBy John R. HansenAugust 2, 2022Leave a comment

In his recent WSJ column “Strong Dollar Wins the Inflation Battle in New Spin on Currency Wars,” James Mackintosh suggests that the dollar’s sharp appreciation

←1
23456
…7891011…
1213141516
17→
  • ABOUT
  • NEWSROOM
  • CONTACT
Facebook-f Youtube Linkedin

© 2026 COALITION FOR A PROSPEROUS AMERICA. ALL RIGHTS RESERVED.

Go to Top

⋆ ⋆ ⋆ MENU

  • HOME
  • ABOUT
    • ABOUT CPA
    • STAFF
    • BOARD
    • ADVOCACY
    • MEMBERSHIP
    • HISTORY
    • OUR MISSION
    • OUR VISION
    • CONTACT US
  • ISSUES
    • AGRICULTURE
    • BUY AMERICAN
    • CHINA
    • CURRENCY
    • DE MINIMIS
    • HEALTHCARE
    • MANUFACTURING
    • RENEWABLE ENERGY
    • TAX
    • TECHNOLOGY
    • TRADE & TARIFFS
  • RESEARCH
  • NEWSROOM
    • THE LATEST
    • NEWSLETTER: PROSPER WEEKLY
    • PRESS RELEASES
    • CPA OPINION
    • LETTERS & TESTIMONY
  • CONTRIBUTE
Prosper Weekly

DON'T MISS IT!

Subscribe to CPA's exclusive weekly Newsletter ➔

 Share This
 Facebook
 LinkedIn
 Copy

Share on Mastodon